Integrins in pulmonary inflammatory diseases

Current Pharmaceutical Design

Volumn 11, Issue 7, 2005, Pages 893-901

  Bazan Socha, S ^a   Bukiej, A ^a   Marcinkiewicz, C ^b   Musial, J ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Temple University   (United States)

Author keywords

Airway remodeling; Bronchial asthma; Emphysema; Inflammation; Integrin antagonists; Integrins; Pulmonary fibrosis

Indexed keywords

ABCIXIMAB; ALPHA4 INTEGRIN ANTAGONIST; ALPHA4 INTEGRIN ANTIBODY; BIO 1211; CELL ADHESION MOLECULE; DISINTEGRIN; EPTIFIBATIDE; GLYCOPROTEIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; NATALIZUMAB; PROTEIN ANTIBODY; PROTEIN INHIBITOR; RECEPTOR BLOCKING AGENT; SELECTIN; STEROID; SYNTHETIC PEPTIDE; TIROFIBAN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4 ANTIBODY; VERY LATE ACTIVATION ANTIGEN 4 INHIBITOR;

ANGIOGENESIS; CELL INTERACTION; CELL SURFACE; CELL SURVIVAL; CLINICAL TRIAL; DRUG TARGETING; EMPHYSEMA; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; LUNG DISEASE; LUNG FIBROSIS; LUNG STRUCTURE; MOLECULAR INTERACTION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ASTHMA; DISINTEGRINS; EMPHYSEMA; HUMANS; INTEGRINS; LEUKOCYTES; METALLOPROTEASES; PNEUMONIA; PULMONARY FIBROSIS; SARCOIDOSIS;

EID: 14744286868     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612053381710     Document Type: Review

References (107)

1. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
2. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868-80.
3. Alvaro M. Adhesion molecules and asthma. Allergol Immunopathol 2000; 28: 110-5.
4. Sato S, Ouellet N, Pelletier I, Simard M, Rancourt A, Bergeron MG. Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J Immunol 2002; 168: 1813-22.
5. Noguera A, Busquets X, Sauleda J, Villaverde JM, MacNee W, Agusti AG. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1664-8.
6. Davis GE. The Mac-1 and p150, 95 β2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp Cell Res 1992; 200: 242-52.
7. Vorup-Jensen T, Ostermeier C, Shimaoka M, Hommel U, Springer TA. Structure and allosteric regulation of the αXβ2 integrin I domain. Proc Natl Acad Sci USA 2003; 100: 1873-8.
8. Van Buul JD, Mul FP, Van Der Schoot CE, Hordijk PL. ICAM-3 Activation Modulates Cell-Cell Contacts of Human Bone Marrow Endothelial Cells. J Vasc Res 2004; 41: 28-37.
9. Simmons DL. The role of ICAM expression in immunity and disease. Cancer Surv 1995; 24: 141-55.
10. Tian L, Kilgannon P, Yoshihara Y, Mori K, Gallatin WM, Carpen O, et al. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with leukocyte integrin CD11a/CD18. Eur J Immunol 2000; 30: 810-8.
11. Drost EM, MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur J Immunol 2002; 32: 393-403.
12. Hogg N, Bates PA. Genetic analysis of integrin function in man: LAD-1 and other syndromes. Matrix Biol 2000; 19: 211-22.
13. Taooka Y, Chen J, Yednock T, Sheppard D. The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 1999; 145: 413-20.
14. Shang T, Yednock T, Issekutz AC. α9β1 integrin is expressed on human neutrophils and contributes to neutrophil migration through human lung and synovial fibroblast barriers. J Leukoc Biol 1999; 66: 809-16.
15. Grayson MH, Van der Vieren M, Sterbinsky SA, Gallatin MW, Hoffman PA, Staunton DE, et al. αDβ2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1). J Exp Med 1998; 188: 2187-91.
16. McNulty CA, Symon FA, Wardlaw AJ. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. Am J Respir Cell Mol Biol 1999; 20: 1251-9.
17. Bochner BS, Sterbinsky SA, Saini SA, Columbo M, Macglashan DW. Studies of cell adhesion and flow cytometric analyses of degranulation, surface phenotype, and viability using human eosinophils, basophils, and mast cells. Methods 1997; 13: 61-8.
18. Boyce JA, Mellor EA, Perkins B, Lim YC, Luscinskas FW. Human mast cell progenitors use α4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 2002; 99: 2890-6.
19. Rihs S, Walker C, Virchow JC Jr, Boer C, Kroegel C, Giri SN, et al. Differential expression of αEβ7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by α4β1-integrin crosslinking and TGF-β. Am J Respir Cell Mol Biol 1996; 15: 600-10.
20. Leckie MJ, Jenkins GR, Khan J, Smith SJ, Walker C, Barnes PJ, et al. Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+). Thorax 2003; 58: 23-9.
21. Lohmeyer J, Friedrich J, Grimminger F, Maus U, Tenter R, Morr H, et al. Expression of mucosa-related integrin αEβ7 on alveolar T cells in interstitial lung diseases. Clin Exp Immunol 1999; 116: 340-6.
22. Bousquet J, Chanez A, Vignola J, Lacoste F, Michel FB. Eosinophil infiltration in asthma. Am J Respir Crit Care Med 1994; 150: 533.
23. Lobb RR, Pepinsky B, Leone DR, Abraham WM. The role of α4 integrins in lung pathophysiology. Eur Respir J Suppl 1996; 22: 104-108.
24. Kikuchi M, Tachimoto H, Nutku E, Hudson SA, Bochner BS. Phorbol esters alter α4 and αD integrin usage during eosinophil adhesion to VCAM-1. Cell Commun Adhes 2003; 10: 119-28.
25. Nagata M, Yamamoto H, Tabe K, Sakamoto Y. Eosinophil transmigration across VCAM-1-expressing endothelial cells is upregulated by antigen-stimulated mononuclear cells. Int Arch Allergy Immunol 2001; 125: 7-11.
26. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992; 148: 1086-1092.
27. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995; 154: 799-803.
28. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, et al. Elevated expression of mRNA encoding interleukin 13 in the bronchial mucosa of atopic and non-atopic asthmatics. J Allergy Clin Immunology 1997; 99: 657-665.
29. Atsuta J, Sterbinsky SA, Plitt J, Schwiebert LM, Bochner BS, Schleimer RP. Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. Am J Respir Cell Mol Biol 1997; 17: 571-82.
30. Spring FA, Parsons SF, Ortlepp S, Olsson ML, Sessions R, Brady RL, et al. Intercellular adhesion molecule-4 binds α4β1 and αV-family integrins through novel integrin-binding mechanisms. Blood 2001; 98: 458-66.
31. Bayless KJ, Meininger GA, Scholtz JM, Davis GE. Osteopontin is a ligand for the α4β1 integrin. J Cell Sci 1998; 111: 1165-74.
32. Fujisaki S, Park YJ, Kimizuka Y, Inoue M, Tomita R, Fukuzawa M, et al. Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) during small-bowel graft rejection in rats. Scand J Gastroenterol 2003; 38: 437-42.
33. Erle DJ, Briskin MJ, Butcher EC, Garcia-Pardo A, Lazarovits AI, Tidswell M. Expression and function of the MAdCAM-1 receptor, integrin α4β7, on human leukocytes. J Immunol 1994; 153: 517-28.
34. Kubes P, Niu XF, Smith CW, Kehrli ME Jr, Reinhardt PH, Woodman RC. A novel β1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 1995; 9: 1103-11.
35. Reinhardt PH, Kubes P. Differential leukocyte recruitment from whole blood via endothelial adhesion molecules under shear conditions. Blood 1998; 92: 4691-9.
36. Walsh GM, Symon FA, Lazarovils AL, Wardlaw AJ. Integrin α4β7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology 1996; 89: 112-9.
37. Okada T, Sagara H, Nakano Y, Hiyama T, Fukuda T. A mechanism for the anti-inflammatory effect of nedocromil; inhibition of both adhesion molecule expression on eosinophils and endothelial cells, and eosinophil chemotactic activities. Arerugi 1999; 48: 1322-30.
38. Bocchino V, Bertorelli G, D'Ippolito R, Castagnaro A, Zhuo X, Grima P, et al. The increased number of very late activation antigen-4-positive cells correlates with eosinophils and severity of disease in the induced sputum of asthmatic patients. J Allergy Clin Immunol 2000; 105: 65-70.
39. Lantero S, Alessandri G, Spallarossa D, Scarso L, Rossi GA. LFA-1 expression by blood eosinophils is increased in atopic asthmatic children and is involved in eosinophil locomotion. Eur Respir J 1998; 12: 1094-8.
40. Berlin M, Lundahl J, Skold CM, Grunewald J, Eklund A. The lymphocytic alveolitis in sarcoidosis is associated with increased amounts of soluble and cell-bound adhesion molecules in bronchoalveolar lavage fluid and serum. J Intern Med 1998; 244: 333-40.
41. Shigehara K, Shijubo N, Hirasawa M, Abe S, Uede T. Immunolocalization of extracellular matrix proteins and integrins in sarcoid lymph nodes. Virchows Arch 1998; 433: 55-61.
42. Saltini C, Hemler ME, Crystal RG. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. Clin Immunol Immunopathol 1988; 46: 221-33.
43. Bank I, Book M, Ware R. Functional role of VLA-1 (CD49a) in adhesion, cation-dependent spreading, and activation of cultured human T lymphocytes. Cell Immunol 1994; 156: 424-37.
44. Popper HH, Pailer S, Wurzinger G, Feldner H, Hesse C, Eber E. Expression of adhesion molecules in allergic lung diseases. Virchows Arch 2002; 440: 172-80.
45. Davidson JM. Biochemistry and turnover of lung interstitium. Eur Respir J 1990; 3: 1048-63.
46. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, et al. Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 2002; 415: 171-5.
47. Kuang PP, Goldstein RH, Liu Y, Rishikof DC, Jean JC, Joyce-Brady M. Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1147-52.
48. Huang XZ, Wu JF, Cass D, Erle DJ, Corry D, Young SG, et al. Inactivation of the integrin β6 Subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol 1996; 133: 921-8.
49. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, et al. Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 2003; 422: 169-73.
50. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003; 111: 215-25.
51. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001; 164: 39-45.
52. Freyer AM, Johnson SR, Hall IP. Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. Am J Respir Cell Mol Biol 2001; 25: 569-76.
53. Wu H, Zhang Y, Xu Z, Zhang J, Zhang X, Zhao Z, The expression of integrin α5β1 and transforming growth factor-β in pulmonary fibrosis of rat. Zhonghua Bing Li Xue Za Zhi 1999; 28: 427-31.
54. White SR, Dorscheid DR, Rabe KF, Wojcik KR, Hamann KJ. Role of very late adhesion integrins in mediating repair of human airway epithelial cell monolayers after mechanical injury. Am J Respir Cell Mol Biol 1999; 20: 787-96.
55. Vignola AM, Bonsignore G, Siena L, Melis M, Chiappara G, Gagliardo R, et al. ICAM-1 and α3β1 expression by bronchial epithelial cells and their in vitro modulation by inflammatory and anti-inflammatory mediators. Allergy 2000; 55: 931-9.
56. Grunstein MM, Hakonarson H, Maskeri N, Kim C, Chuang S. Intrinsic ICAM-1/LFA-1 activation mediates altered responsiveness of atopic asthmatic airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1154-63.
57. Scaffidi AK, Moodley YP, Weichselbaum M, Thompson PJ, Knight DA. Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins. J Cell Sci 2001; 114: 3507-16.
58. Levine D, Rockey DC, Milner TA, Breuss JM, Fallon JT, Schnapp LM. Expression of the integrin α8β1 during pulmonary and hepatic fibrosis. Am J Pathol 2000; 156: 1927-35.
59. Wagner TE, Frevert CW, Herzog EL, Schnapp LM. Expression of the integrin subunit α8 in murine lung development. J Histochem Cytochem 2003; 51: 1307-15.
60. Lu M, Munger JS, Steadele M, Busald C, Tellier M, Schnapp LM. Integrin α8β1 mediates adhesion to LAP-TGFβ1. J Cell Sci 2002; 115: 4641-8.
61. White ES, Thannickal VJ, Carskadon SL, Dickie EG, Livant DL, Markwart S, et al. Integrin α4β1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 2003; 168: 436-42.
62. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107: 295-301.
63. Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, et al. Central roles of α5β1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 2002; 22: 927-33.
64. Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins. Proc Natl Acad Sci USA 2003; 100: 4766-71.
65. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parry GC, Parikh AA, et al. Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer 2003; 104: 496-503.
66. Pedchenko V, Zent R, Hudson BG. αvβ3 and αvβ5 integrins bind both the proximal RGD site and non-RGD motifs within noncollagenous (NC1) domain of the α3 chain of type IV collagen: implication for the mechanism of endothelial cell adhesion. J Biol Chem 2004; 279: 2772-2780.
67. Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, et al. αvβ3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res 2003; 63: 2079-87.
68. Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc Natl Acad Sci USA 1997; 94: 13612-7.
69. Marneros AG, Olsen BR. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol 2001; 20: 337-45.
70. Marcinkiewicz C, Weinreb PH, Calvete JJ, Kisiel DG, Mousa SA, Tuszynski GP, et al. Obtustatin: a potent selective inhibitor of α1β1 integrin in vitro and angiogenesis in vivo. Cancer Res 2003; 63: 2020-3.
71. Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA. Elevated matrix metalloprotease and angiostatin levels in integrin α1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 2000; 97: 2202-7.
72. Jackson DY. α4 integrin antagonists. Curr Pharm Des 2002; 8: 1229-53.
73. Kudlacz E, Whitney C, Andresen C, Duplantier A, Beckius G, Chupak L, et al. Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule α4β1 antagonists. J Pharmacol Exp Ther 2002; 301: 747-52.
74. Henderson WR Jr, Chi EY, Albert RK, Chu SJ, Lamm WJ, Rochon Y, et al. Blockade of CD49d (α4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997; 100: 3083-92.
75. Kanehiro A, Takeda K, Joetham A, Tomkinson A, Ikemura T, Irvin CG, et al. Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice. Am J Respir Crit Care Med 2000; 162: 1132-9.
76. Borchers MT, Crosby J, Farmer S, Sypek J, Ansay T, Lee NA, et al. Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001; 280: L813-21.
77. Schwarze J, Cieslewicz G, Hamelmann E, Joetham A, Shultz LD, Lamers MC, et al. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol 1999; 162: 2997-3004.
78. Sagara H, Matsuda H, Wada N, Yagita H, Fukuda T, Okumura K, et al. A monoclonal antibody against very late activation antigen-4 inhibits eosinophil accumulation and late asthmatic response in a guinea pig model of asthma. Int Arch Allergy Immunol 1997; 112: 287-94.
79. Jackson DY, Quan C, Artis DR, Rawson T, Blackburn B, Struble M, et al. Potent α4β1 peptide antagonists as potential anti-inflammatory agents. J Med Chem 1997; 40: 3359-68.
80. Sircar I, Gudmundsson KS, Martin R, Liang J, Nomura S, Jayakumar H, et al. Synthesis and SAR of N-benzoyl-L-biphenylalanine derivatives: discovery of TR-14035, a dual α4β7/α4β1 integrin antagonist. Bioorg Med Chem 2002; 10: 2051-66.
81. Lin K, Ateeq HS, Hsiung SH, Chong LT, Zimmerman CN, Castro A, et al. Selective, tight-binding inhibitors of integrin α4β1 that inhibit allergic airway responses. J Med Chem 1999; 42: 920-34.
82. Zhu GD, Arendsen DL, Gunawardana IW, Boyd SA, Stewart AO, Fry DG, et al. Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. Aryl modifications of 4-(aryloxy) thieno[2, 3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001; 44: 3469-87.
83. Singh J, Van Vlijmen H, Liao Y, Lee WC, Cornebise M, Harris M, et al. Identification of potent and novel α4β1 antagonists using in silico screening. J Med Chem 2002; 45: 2988-93.
84. Abraham WM, Gill A, Ahmed A, Sielczak MW, Lauredo IT, Botinnikova Y, et al. A small-molecule, tight-binding inhibitor of the integrin α4β1 blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med 2000; 162: 603-11.
85. Lobb RR, Adams SP. Small molecule antagonists of α4 integrins: novel drugs for asthma. Exp Opin Invest Drugs 1999; 8: 935-945.
86. Vanderslice P, Biediger RJ, Woodside DG, Berens KL, Holland GW, Dixon RA. Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD. Pulm Pharmacol Ther 2004; 17: 1-10.
87. Ghosh S. α4 integrin blockade in inflammatory bowel disease. Ann Rheum Dis 2003; 62: 70-72.
88. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990; 8: 365-400.
89. Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE, et al. Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis. J Clin Invest 2002; 110: 1773-82.
90. De Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, Gardner H, et al. Regulation of inflammation by collagen-binding integrins α1β1 and α2β 1 in models of hypersensitivity and arthritis. J Clin Invest 2000; 105: 721-9.
91. Abraham WM, Ahmed A, Serebriakov I, Carmillo AN, Ferrant J, de Fougerolles AR, et al. A monoclonal antibody to α1β1 blocks antigen-induced airway responses in sheep. Am J Respir Crit Care Med 2004; 169: 97-104.
92. Gascoigne MH, Holland K, Page CP, Shock A, Robinson M, Foulkes R, et al. The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits. Pulm Pharmacol Ther 2003; 16: 279-85.
93. Burke-Gaffney A, Hellewell PG. A CD18/ICAM-1-dependent pathway mediates eosinophil adhesion to human bronchial epithelial cells. Am J Respir Cell Mol Biol 1998; 19: 408-18.
94. Taylor BM, Kolbasa KP, Chin JE, Richards IM, Fleming WE, Griffin RL, et al. Roles of adhesion molecules ICAM-1 and α4 nintegrin in antigen-induced changes in microvascular permeability associated with lung inflammation in sensitized brown Norway rats. Am J Respir Cell Mol Biol 1997; 17: 757-66.
95. Papayannopoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci USA 1993; 90: 9374-8.
96. Blobel CP, White JM. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol 1992; 4: 760-765.
97. Duffy MJ, Lynn DJ, Lloyd AT, O'Shea CM. The ADAMs family of proteins: from basic studies to potential clinical applications. Thromb Haemost 2003; 89: 622-31.
98. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997; 272: 556-62.
99. Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418: 426-30.
100. Holgate ST, Davies DE, Murphy G, Powell RM, Holloway JW. ADAM 33: just another asthma gene or a breakthrough in understanding the origins of bronchial hyperresponsiveness? Thorax 2003; 58: 466-9.
101. Lefkovitz J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553-1559.
102. Bennett JS. Novel platelet inhibitors. Ann Rev Med 2001; 52: 161-184.
103. Nagel H, Maag S, Tassis A, Nestle FO, Greber UF, Hemmi S. The αvβ5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses. Gene Ther 2003; 10: 1643-53.
104. Davison E, Kirby I, Whitehouse J, Hart I, Marshall JF, Santis G. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by αvβ1 integrin and can be modulated by changes in β1 integrin function. J Gene Med 2001; 3: 550-9.
105. Kugler MC, Wei Y, Chapman HA. Urokinase receptor and integrin interactions, Curr Pharm Design 2003; 9(19): 1565-74.
106. Reid PT, Sallenave JM. Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Design 2003; 9(1): 25-38.
107. Sato Y. Modulation of PMN-endothelial cells interactions by cyclic nucleotides. Curr Pharm Design 2004; 10(2): 163-70.